21.4.2024 12:20:17 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state
Reference is made to the stock exchange announcement made by Thor Medical ASA
(the "Company") the Company on 11 April 2024 whereby it was disclosed that the
Company's annual meeting resolved ("AGM"), among other things, the approval of a
restricted share units ("RSU") program.
At the AGM, the shareholders approved the remuneration to the Company's current
board of directors whereby the board members were given the choice to receive
their remuneration, or a part thereof, for the period from the AGM to the annual
general meeting of 2025, in the form of restricted share units ("RSU"), as a
part of the Company's RSU program.
Each board member had the following three alternatives:
? Receive 100 % of the board remuneration in the form of RSUs